SCHEMBL27459999

SCHEMBL27459999

CC(Nc1ccccc1)C(=O)N1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ GAA P10253 4/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CTSL P07711 1/20 0.48
▸ CTSB P07858 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HPGD P15428 4/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TSHR P16473 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31378269 0.98 CTSL (0.49) ALDH1A1HTTGAALMNACTSL
Trifluoroacetic Acid SCHEMBL6567389 0.90 CTSL (0.43) ALDH1A1HTTGAALMNACTSL
SCHEMBL9155829 0.83 ALDH1A1 (0.45) ALDH1A1HTTLMNACTSLCTSB
SCHEMBL31262932 0.81 CTSL (0.49) ALDH1A1HTTGAALMNACTSL
SCHEMBL8156953 0.80 ITGB3 (0.50) SMN1; SMN2RAB9A
Hydrochloric Acid SCHEMBL5891447 0.80 F10 (0.46) MEN1KMT2ANPC1
SCHEMBL31262880 0.79 CTSL (0.50) ALDH1A1HTTGAALMNACTSL
SCHEMBL9158363 0.79 GAA (0.46) ALDH1A1GAALMNACTSLCTSB
SCHEMBL9158357 0.79 GAA (0.46) ALDH1A1GAALMNACTSLCTSB
SCHEMBL9158572 0.77 GAA (0.50) ALDH1A1HTTGAALMNACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1125054-C Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them AVENTIS PHARMACEUTICS GMBH (DE) 2003-10-22 — — CN disclosed
Send feedback